| Autor: |
Solanich, X., Padullés, N., Niubó, J., Videla, S., Antolí, A., Rocamora‐Blanch, G., Corbella, X., Rocamora-Blanch, G |
| Předmět: |
|
| Zdroj: |
Journal of Internal Medicine; Jun2021, Vol. 289 Issue 6, p926-927, 2p |
| Abstrakt: |
Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: are concentrations required clinically achievable? Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease: a pilot study. B Dear Editor, b We read with great interest the article by Galvez-Romero et al. entitled 'Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text